Abstract
Piperaquine phosphate is an orally active bisquinolone antimalarial drug that has been used for the past 3 decades. The authors report the safety, tolerability, and pharmacokinetics of piperaquine from a classical controlled phase I study. It was a double-blind, randomized, parallel-group, placebo-controlled, and single- and multiple-dose study. During the rising single-dose study, single ascending oral doses of 500, 750, 1000, 1250, and 1500 mg of piperaquine phosphate were administered, whereas in rising multiple-dose study, once-daily ascending oral doses of 500, 750, 1000, and 1500 mg were administered for 3 consecutive days. Pharmacokinetic analysis for both the rising single- and multiple-dose studies was done using the noncompartmental approach. The mean apparent terminal half-life ranged from 11 to 23 days. Increase in exposure was less than dose proportional and linear. Piperaquine concentrations were measurable up to 60 days postdose. Multiple peaks were observed in the plasma piperaquine concentration-time profiles and exhibited 3- to 7-fold accumulation following multiple dosing. Piperaquine was well tolerated following single and multiple doses.
References
Jun 12, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Te-Yu HungKenneth F Ilett
Jan 16, 2004·Lancet·Tinh Hien TranJeremy Farrar
Mar 5, 2004·British Journal of Clinical Pharmacology·Te-Yu HungDoung Socheat
Dec 22, 2004·Drugs·Timothy M E DavisKenneth F Ilett
May 21, 2005·Journal of Pharmaceutical and Biomedical Analysis·N LindegårdhN P J Day
May 27, 2005·Antimicrobial Agents and Chemotherapy·Ing-Kye SimKenneth F Ilett
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Joel TarningNicholas J White
Mar 30, 2006·European Journal of Clinical Pharmacology·Daniel RöshammarMichael Ashton
Citations
Jun 29, 2011·Antimicrobial Agents and Chemotherapy·Anna AnnerbergFrançois Nosten
Dec 3, 2008·Antimicrobial Agents and Chemotherapy·Nguyen Trong ChinhMichael D Edstein
Apr 4, 2012·Antimicrobial Agents and Chemotherapy·Sam SalmanTimothy M E Davis
Nov 3, 2010·Annual Review of Pharmacology and Toxicology·Thomas E Scammell, Christopher J Winrow
Sep 29, 2009·PloS One·Badara CissePaul Milligan
Jan 29, 2016·Malaria Journal·Neena ValechaAnupkumar R Anvikar
Feb 26, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Offianan Andre TourePaul Swoboda
Oct 30, 2010·Trends in Parasitology·Ronan JambouMilijaona Randrianarivelojosia
Nov 7, 2009·Reproductive Toxicology·Kevin T BattyTimothy M E Davis
Jul 1, 2008·Acta Tropica·Trinh Ngoc HaiMichael Ashton
Mar 4, 2015·Clinical Pharmacology and Therapeutics·N C SambolS Parikh
Mar 26, 2009·Experimental Parasitology·D M KiboiA Nzila
Nov 9, 2015·European Journal of Drug Metabolism and Pharmacokinetics·Iftekhar MahmoodRita Humeniuk
May 10, 2018·The American Journal of Tropical Medicine and Hygiene·Nguyen Ngoc QuangMichael D Edstein
Aug 6, 2014·Antimicrobial Agents and Chemotherapy·S M D K Ganga Senarathna, Kevin T Batty
Jun 3, 2016·Expert Review of Anti-infective Therapy·Johannes MischlingerMichael Ramharter
Jul 16, 2017·Biopharmaceutics & Drug Disposition·Olusola OlafuyiRaj K S Badhan
Jan 31, 2019·Nature Communications·Palang ChotsiriJoel Tarning
Jul 12, 2017·British Journal of Clinical Pharmacology·Palang ChotsiriJoel Tarning
Apr 29, 2015·Antimicrobial Agents and Chemotherapy·Issaka ZongoJean-Bosco Ouedraogo